Oct 9, 2026 08:01AM

Mar 9, 2024 04:00PM

Oct 20, 2023 08:01AM

Oct 6, 2023 08:00AM

Sep 20, 2022 11:09AM

Jul 29, 2022 04:05PM

Jul 11, 2022 08:04AM Arcutis Biotherapeutics Inc. (ARQT) Announces Health Canada Accepts for Review the New Drug Submission for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis

Mar 25, 2022 07:31AM

Mar 25, 2022 07:30AM

Sep 30, 2021 08:40AM

May 6, 2021 08:46AM

Feb 1, 2021 09:30AM

Feb 1, 2021 07:31AM

Oct 6, 2020 04:05PM Arcutis Biotherapeutics Announces Closing of Public Offering and Concurrent Private Placement of Common Stock

Oct 2, 2020 06:11AM

Oct 1, 2020 10:47PM

Sep 29, 2020 04:52PM

Sep 29, 2020 04:51PM

Sep 29, 2020 04:20PM

Sep 29, 2020 08:07AM

Sep 16, 2020 09:14AM Arcutis Biotherapeutics Inc. (ARQT) Reports Complete Enrollment in DERMIS-1 & DERMIS-2 Pivotal Phase 3 Clinical Trials Evaluating ARQ-151 as Potential Treatment for Plaque Psoriasis

Aug 3, 2020 09:04AM

Jul 15, 2020 05:08PM

Mar 16, 2020 08:47AM

Mar 16, 2020 08:37AM

Mar 16, 2020 08:37AM

Feb 13, 2020 08:33AM

Jan 21, 2020 09:10AM Form S-1/A Arcutis Biotherapeutics,

68,863 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All